Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
 |
2017 –2031 |
 |
USD 1.65 Billion |
 |
USD 6.68 Billion |
 |
% |
|
|
Global Microbiome Sequencing Services Market, By Technology (Sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, and Other Technologies), Laboratory Type (Dry Labs and Wet Labs), Research Type (Outsourced Research and Internal Research), Application (Shotgun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Whole Genome Sequencing, and Other Applications), End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Others) – Industry Trends and Forecast to 2031.
The microbiome sequencing services market sees continuous advancement by integrating high-throughput technologies, AI-driven analytics, and multi-omics approaches. This evolution enables deeper insights into microbial communities, facilitating personalized medicine, agricultural enhancements, and environmental monitoring. Enhanced accuracy, efficiency, and scalability characterize the modern landscape, driving innovation and expanding applications across various sectors.
For instance, according to the National Human Genome Research Institute of the United States National Institute of Health, as biomedical research projects and large-scale collaborations expand, genomic data generation is surging, reaching approximately 2 to 40 billion gigabytes annually as of April 2022.
Data Bridge Market Research analyses that the global microbiome sequencing services market size was valued at USD 1.65 billion in 2023, is projected to reach USD 6.68 billion by 2031, with a CAGR of 19.05% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, and Other Technologies), Laboratory Type (Dry Labs and Wet Labs), Research Type (Outsourced Research and Internal Research), Application (Shotgun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Whole Genome Sequencing, and Other Applications), End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America
|
|
Market Players Covered
|
Baseclear B.V. (Netherlands), Zymo Research Corporation. (U.S.), Second Genome (U.S.), MR DNA (Molecular Research LP) (U.S.), Microbiome Therapeutics Innovation Group (U.S.), Microbiome Insights (Canada), Locus Biosciences, Inc. (U.S.), Mérieux NutriSciences Corporation (France), Clinical-Microbiomics A/S (Denmark), OpenBiome (U.S.), Shanghai Ruiyi Biotechnology Co., Ltd. (China), Rancho Bio Sciences (U.S.), Resphera Biosciences, LLC (U.S.), Diversigen (U.S.), Molzym GmbH & Co. KG (Germany), BioSpherex LLC (U.S.), and TGen (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Microbiome sequencing services analyze the genetic material of microorganisms in a specific environment, such as the human gut or soil. These services employ advanced techniques to identify and characterize microbial communities, offering insights into their diversity, composition, and functional potential. Such analysis is crucial for understanding microbial ecology and its implications for health, agriculture, and the environment.
Drivers
Continuous advancements in next-generation sequencing (NGS) technologies have significantly enhanced sequencing speed, accuracy, and cost-effectiveness. This progress is a key driver propelling the growth of microbiome sequencing services. Faster, more precise, and affordable sequencing capabilities facilitate broader adoption of microbiome analysis across various industries and research domains, fueling market expansion.
For instance, a study in the April 2022 Journal of Clinical Investigation highlights how Next-generation sequencing (NGS) technology enhances comprehension of the human microbiome by identifying and characterizing unculturable microbes and predicting their functions. These innovations are anticipated to drive growth in microbiome sequencing services.
The integration of sequencing platforms with automated sample preparation and data analysis workflows enhances efficiency and reduces turnaround times. This technological advancement accelerates market growth by meeting the increasing demand for microbiome sequencing services while improving accessibility and affordability, thereby driving adoption across various research and application domains.
Opportunities
Microbiome sequencing in agriculture enhances crop yield, soil health, and environmental sustainability, driving demand for sequencing services. Farmers can optimize crop management practices, mitigate soil degradation, and develop eco-friendly solutions by analyzing microbial communities. This growing application presents significant growth opportunities for microbiome sequencing service providers in the agricultural and environmental sectors.
Biotechnology and pharmaceutical sectors are integrating microbiome analysis into drug research and development, spurring demand for sequencing services. Microbiome insights are crucial for understanding drug efficacy, safety, and personalized treatments. This trend drives significant growth in microbiome sequencing services, catering to industry needs for comprehensive microbial data in therapeutic development pipelines.
For instance, in March 2022, Microbiotica secured USD 67 million to advance its microbiome-based immuno-oncology research, earmarked for Phase 1b trials slated to commence later in the year. This substantial funding underscores the growing interest and investment in microbiome-related therapies for oncological applications.
Restraints/Challenges
Microbiome sequencing raises ethical concerns due to collecting personal biological data, necessitating stringent adherence to privacy regulations and consent protocols. Ensuring data security is challenging, especially in large-scale research or clinical trials, highlighting the need for robust ethical frameworks to safeguard sensitive information responsibly.
Microbiome sequencing services can be prohibitively expensive due to the need for advanced technology and expertise. This cost presents accessibility barriers for smaller research entities or organizations with limited budgets, impeding their ability to utilize this technology for microbiome analysis and research purposes, potentially limiting the scope and depth of their scientific investigations in this field.
This global autoimmune disease diagnosis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global autoimmune disease diagnosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
The market is segmented on the basis of technology, laboratory type, research type, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
Laboratory Type
Research Type
Application
End User
The market is analysed and market size insights and trends are provided by country, technology, laboratory type, research type, application, and end-user as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
North America is expected to dominate the market due to favorable reimbursement policies by governmental bodies in the region. This encourages adoption and facilitates accessibility, driving growth and innovation within the microbiome sequencing industry.
Asia-Pacific is expected to witness significant growth in the market, attributed to the burgeoning healthcare infrastructure development in the region. This trend underscores the region's increasing focus on advanced healthcare solutions, fostering market expansion during the forecast period.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
The market is segmented based on , By Technology (Sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, and Other Technologies), Laboratory Type (Dry Labs and Wet Labs), Research Type (Outsourced Research and Internal Research), Application (Shotgun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Whole Genome Sequencing, and Other Applications), End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Others) – Industry Trends and Forecast to 2031. .
The Global Microbiome Sequencing Services Market size was valued at USD 1.65 USD Billion in 2016.
The Global Microbiome Sequencing Services Market is projected to grow at a CAGR of 19.05% during the forecast period of 2017 to 2031.
The major players operating in the market include Baseclear B.V. ,Zymo Research Corporation. ,Second Genome ,MR DNA ,Microbiome Therapeutics Innovation Group ,Microbiome Insights ,Locus BiosciencesInc. ,Mé,rieux NutriSciences Corporation ,Clinical-Microbiomics A/S ,OpenBiome ,Shanghai Ruiyi Biotechnology Co.Ltd. ,Rancho Bio Sciences ,Resphera BiosciencesLLC ,Diversigen ,Molzym GmbH &, Co. KG ,BioSpherex LLC ,TGen .
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.
